Clinical Trials Logo

Healthy Male clinical trials

View clinical trials related to Healthy Male.

Filter by:

NCT ID: NCT01651234 Completed - Healthy Male Clinical Trials

A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers

Start date: March 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and characterize the PK, PD f\profile.

NCT ID: NCT01359618 Terminated - Healthy Male Clinical Trials

Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart

Start date: June 2011
Phase: Phase 1
Study type: Interventional

This is a two part study. Part A will determine the maximum tolerated dose of TC-5214 administered to healthy male subjects in single ascending oral doses. This part of the study will define the highest dose of TC-5214 to be administered in Part B. Part B of this study will investigate the effect of TC-5214 on the electrical activity of the heart following single oral administration. The study will be carried out healthy male subjects in a four period crossover study with TC-5214 compared to placebo and oral moxifloxacin as a positive control. The safety, tolerability and pharmacokinetics of TC-5214 will also be evaluated.